# Variceal Bleeding Initial Management

Treat suspected acute variceal bleeding as a portal-hypertensive emergency: resuscitate without overtransfusion, immediately start vasoactive therapy and antibiotic prophylaxis, then perform therapeutic endoscopy after hemodynamic stabilization, generally within 12 hours. Identify patients needing early or salvage portal decompression.

**Clinical question:** How should physicians stabilize, treat, and escalate care for suspected acute esophageal or gastric variceal bleeding?

Updated: 2026-09-15T18:40:04.694447+00:00

## What matters in practice
- Start a vasoactive agent and antibiotic prophylaxis at presentation when acute variceal bleeding is suspected; do not wait for endoscopic confirmation. [7][16]
- Use restrictive red-cell transfusion, targeting hemoglobin 7-9 g/dL; transfuse immediately despite a higher hemoglobin when severe bleeding causes hemodynamic instability. [17][21][13]
- After hemodynamic resuscitation, perform upper endoscopy within 12 hours; endoscopic variceal ligation is preferred for bleeding esophageal varices. [16][20][7]
- Avoid routine correction of abnormal coagulation parameters with blood products solely to normalize laboratory values in acute variceal bleeding. [2]
- Consider preemptive covered TIPS within 72 hours after the index bleed for Child-Pugh B cirrhosis with active bleeding at endoscopy or Child-Pugh C cirrhosis with score below 14. [7]

## Manage suspected variceal bleeding before endoscopic confirmation

Activate a monitored, multidisciplinary hemorrhage pathway at presentation.

Suspected acute variceal bleeding warrants management in a high-dependency unit or an appropriately staffed acute bleeding unit. The initial priorities are airway assessment, hemodynamic resuscitation, early pharmacologic therapy, and coordination of therapeutic endoscopy; delayed endoscopy after resuscitation is associated with worse outcomes in cirrhotic variceal hemorrhage. [1][20]

Do not use hemoglobin alone to judge immediate transfusion need during active exsanguination. A restrictive strategy uses red-cell transfusion when hemoglobin is 7 g/dL or lower, with a 7-9 g/dL target; severe bleeding with hemodynamic instability requires emergent transfusion regardless of the measured hemoglobin. [17][21][13]

Obtain Child-Pugh and MELD scores during the initial assessment and document active versus inactive bleeding at endoscopy. These variables are specifically recommended for risk stratification and determine candidacy for preemptive portal decompression. [16][7]
- Use intensive monitoring or a high-dependency setting for suspected or proven variceal hemorrhage. [1]
- Treat hematemesis with impaired airway protection, coma, or encephalopathy as an aspiration-risk situation before endoscopy; balloon tamponade in these settings should be preceded by prophylactic orotracheal intubation. [23]
- Do not routinely administer fresh frozen plasma, platelets, or cryoprecipitate merely to correct abnormal coagulation parameters; volume loading can worsen portal hypertension and overload. [2]

*Immediate actions for suspected acute variceal bleeding. [7][16][21]*

| Clinical decision | Action | Operational target or implication |
| --- | --- | --- |
| Red-cell replacement | Use restrictive transfusion. | Transfuse at hemoglobin 7 g/dL or lower; target 7-9 g/dL. Override the threshold for severe bleeding with hemodynamic instability. [17][21][13] |
| Portal-pressure reduction | Start octreotide, terlipressin, or somatostatin immediately. | Continue vasoactive treatment for up to 5 days. [16][7] |
| Infection prophylaxis | Give ceftriaxone. | Ceftriaxone 1 g/day for up to 7 days, adjusted to local resistance patterns and allergy considerations. [16] |
| Endoscopic preparation | Administer intravenous erythromycin if no contraindication. | Erythromycin 250 mg IV 30-120 minutes before upper endoscopy. [16] |
| Coagulation tests | Interpret abnormal values in the portal-hypertensive context. | Do not routinely correct abnormal coagulation parameters with blood products. [2] |

## Initiate vasoactive therapy and ceftriaxone immediately

Pharmacologic treatment is concurrent with resuscitation, not a bridge to diagnostic delay.

Start terlipressin, octreotide, or somatostatin at the time of presentation when acute variceal bleeding is suspected and continue for up to 5 days. If terlipressin or somatostatin is unavailable, octreotide is an accepted alternative in UK guidance. [16][7]

When octreotide is selected, use a 50 microgram IV bolus followed by continuous infusion at 50 micrograms/hour for 2-5 days. Vasoactive therapy plus endoscopic treatment improves initial bleeding control and 5-day hemostasis compared with endoscopic treatment alone, although survival benefit was not shown in the cited meta-analysis. [23][7]

Administer antibiotic prophylaxis to every patient with advanced chronic liver disease and acute variceal hemorrhage. ESGE recommends ceftriaxone 1 g/day for up to 7 days, with agent selection informed by local resistance patterns and allergies. [16] In acute gastric variceal bleeding, the same initial antibiotic approach is recommended, including ceftriaxone 1 g daily for a maximum of 7 days. [21]
- Give IV erythromycin 250 mg 30-120 minutes before endoscopy when not contraindicated; this is intended to improve procedural conditions in suspected acute variceal hemorrhage. [16]
- Do not delay vasoactive therapy or antibiotics while awaiting endoscopy, imaging, or confirmation of varices. [7][16]
- For suspected gastric as well as esophageal variceal bleeding, begin restrictive resuscitation, antibiotic prophylaxis, and vasoactive therapy while planning endoscopic source classification. [21]

*Source-supported pre-endoscopic drug regimen. [16][23]*

| Intervention | Dose and timing | Duration or decision point |
| --- | --- | --- |
| Octreotide | 50 microgram IV bolus, then 50 micrograms/hour continuous IV infusion. [23] | Continue for 2-5 days. [23] |
| Alternative vasoactive agents | Terlipressin or somatostatin, initiated at presentation. [16] | Continue vasoactive treatment for up to 5 days. [16] |
| Ceftriaxone | 1 g/day. [16] | Up to 7 days; account for local resistance patterns and drug allergy. [16] |
| Erythromycin | 250 mg IV. [16] | Give 30-120 minutes before upper endoscopy if no contraindication. [16] |

## Perform therapeutic endoscopy after resuscitation

Procedure timing should follow stabilization, not a rigid clock in an unstable patient.

Perform upper endoscopy within 12 hours of presentation after hemodynamic resuscitation in suspected acute variceal hemorrhage. AASLD guidance similarly supports endoscopy within 12 hours, whereas UK guidance allows up to 24 hours for patients who are not severely unstable; the immediate priority in unstable patients is to make endoscopy safe through resuscitation. [16][20][15][17]

For esophageal variceal bleeding, endoscopic variceal ligation is the preferred endoscopic hemostatic technique. Compared with sclerotherapy when combined with vasoactive therapy, ligation produced better 72-hour hemostasis and fewer complications in one randomized trial and lower acute failure to control bleeding in another. [7]

At endoscopy, record active versus inactive bleeding and use the finding together with Child-Pugh and MELD scores for post-hemostasis risk stratification. Active bleeding at the initial examination, stigmata of recent hemorrhage, and large varices predict early recurrence. [16][6]
- Do not prioritize ultra-urgent endoscopy over adequate resuscitation: meta-analysis data did not show lower mortality or rebleeding with earlier timing, and urgent procedures may be harmful in lower-risk patients when visualization and procedural quality are compromised. [8]
- Use endoscopy to identify whether the bleeding source is esophageal or gastric, because subsequent definitive therapy differs. [21]
- If endoscopic hemostasis cannot be achieved in massive hemorrhage, use temporary bridge therapy while arranging definitive intervention rather than persisting with ineffective endoscopic attempts. [23]

### When the source is gastric

For acute gastric variceal bleeding, obtain contrast-enhanced cross-sectional imaging with portal venous phase after initial stabilization to define the variceal complex and guide definitive therapy. Endoscopic documentation should include estimated size, high-risk stigmata, and classification as GOV1, GOV2, IGV1, or IGV2. [21]

Patients with gastric varices may require care at a specialized center when local endoscopic and interventional expertise is unavailable. The initial resuscitation, vasoactive treatment, antibiotic prophylaxis, and endoscopy-within-12-hours framework remains the same as for esophageal variceal bleeding. [21]
- For cardiofundal gastric varices, consider early TIPS in appropriate candidates because of high rebleeding risk; balloon-occluded retrograde transvenous obliteration is an alternative definitive approach in selected anatomy. [23]
- After retrograde transvenous obliteration, evaluate for increased portal-pressure complications, including new or worsened esophageal varices; upper endoscopy at 1-2 months is recommended, with consideration of a 2-week examination when pre-existing high-risk esophageal varices are present. [22]

## Select early TIPS or salvage therapy when standard control is insufficient

Escalate according to endoscopic control, liver severity, and early rebleeding risk.

Consider preemptive covered TIPS within 72 hours after the index variceal bleed in Child-Pugh B cirrhosis with active bleeding at initial endoscopy or Child-Pugh C cirrhosis with a score below 14. This is an early post-hemostasis strategy for patients at high risk of treatment failure, not primary prevention of a first bleed. [7][19]

Define early treatment failure as inability to control bleeding or recurrent bleeding within the first 5 days. Persistent or recurrent hemorrhage after pharmacologic and endoscopic treatment requires salvage portal decompression; TIPS is identified as salvage therapy when medical and endoscopic measures fail. [17][19]

For uncontrolled massive bleeding while definitive treatment is being arranged, balloon tamponade is a temporary bridge for a maximum of 24 hours in intensive-care conditions. Covered self-expanding esophageal stents are an alternative bridge and may have fewer serious adverse events. [23]
- Do not use TIPS as primary prophylaxis for esophageal variceal bleeding. [19]
- Treat balloon tamponade as a bridge only; prolonged placement beyond 24 hours is not recommended. [23]
- In a comatose or encephalopathic patient requiring balloon tamponade, intubate prophylactically because aspiration pneumonia risk is high. [23]

*Escalation after initial endoscopic and pharmacologic treatment. [7][17][19][23]*

| Clinical state | Next intervention | Timing or limiting condition |
| --- | --- | --- |
| Child-Pugh B with active bleeding at index endoscopy | Consider preemptive covered TIPS. [7] | Within 72 hours after the index bleed. [7] |
| Child-Pugh C with score below 14 | Consider preemptive covered TIPS. [7] | Within 72 hours after the index bleed. [7] |
| Failure to control bleeding or recurrent bleeding within 5 days | Proceed to salvage TIPS when standard medical and endoscopic treatment fails. [17][19] | Escalate urgently after failure is recognized. [19] |
| Massive uncontrolled bleeding during transfer or TIPS preparation | Temporary balloon tamponade or covered self-expanding esophageal stent. [23] | Balloon tamponade for no more than 24 hours. [23] |

## Monitor for early rebleeding and complete risk-directed disposition

The highest-risk interval begins immediately after apparent endoscopic hemostasis.

Continue vasoactive therapy for up to 5 days and antibiotic prophylaxis with ceftriaxone for up to 7 days after presentation, while monitoring for recurrent hematemesis, hemodynamic deterioration, and early treatment failure. Rebleeding within 5 days is part of the treatment-failure definition and should prompt salvage-pathway reassessment rather than routine observation. [16][17][19]

Use the endoscopic findings and liver-severity scores to determine whether ongoing ward-level care is adequate or whether early TIPS evaluation is indicated. Active bleeding at index endoscopy and large varices are recurrence markers, while Child-Pugh and MELD stratification is recommended in acute variceal bleeding. [6][16]

For patients treated for gastric varices with retrograde transvenous obliteration, obtain close-interval contrast-enhanced CT to confirm obliteration. Guidance differs on timing, ranging from 2-3 days to 4-6 weeks; incomplete obliteration may require further endoscopic treatment or TIPS. [22]
- Use 5-day recurrent bleeding as a hard escalation trigger, not simply as a marker of prolonged hospitalization. [17]
- After successful retrograde transvenous obliteration, arrange upper endoscopy in 1-2 months to identify new or progressive esophageal varices caused by increased portal pressure. [22]
- Consider liver transplantation in the longer-term plan after gastric-variceal intervention when clinically appropriate. [22]

## Common questions

### Should abnormal INR or thrombocytopenia be routinely corrected before endoscopy in acute variceal bleeding?

No. Baveno VII-oriented guidance advises against routinely correcting abnormal coagulation parameters with blood products in acute variceal bleeding because added volume may worsen portal hypertension and volume overload. [2]

### Does every patient with suspected acute variceal bleeding need endoscopy within 12 hours?

Endoscopy within 12 hours after hemodynamic resuscitation is recommended by ESGE and reflected in AASLD guidance. In patients who remain unstable, stabilization determines when endoscopy is safe; evidence does not establish a mortality benefit for ultra-urgent procedures before adequate resuscitation. [16][20][8]

## References
1. British Society of Gastroenterology position statement on the American Association for the Study of Liver Disease practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis | Frontline Gastroenterology — fg.bmj.com — https://fg.bmj.com/content/early/2026/06/04/flgastro-2026-103698
2. P362 Comparing the impact of baveno vii consensus statement on pre-endoscopy management and outcomes in patients with suspected acute variceal bleeding | Gut — gut.bmj.com — https://gut.bmj.com/content/73/Suppl_1/A272.1
3. Abstracts - Gut — gut.bmj.com — https://gut.bmj.com/content/57/Suppl_1/A1
4. Inflammatory bowel disease Endoscopy free papers - Gut — gut.bmj.com — https://gut.bmj.com/content/gutjnl/57/Suppl_1/A1.full.pdf
5. Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa1912484
6. Gastroesophageal Variceal Hemorrhage — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMra003007
7. UK guidelines on the management of variceal haemorrhage in ... - Gut — gut.bmj.com — https://gut.bmj.com/content/64/11/1680
8. Optimal endoscopy timing in patients with acute variceal bleeding: A systematic review and meta-analysis | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-020-60866-x
9. Acute variceal bleeding and out-of-hours endoscopy: Evaluation of an emergency care setting according to Baveno VI guidelines adherence — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1590865821003765
10. Assessing the Relevance of Baveno VI Guidelines... : Gastroenterology, Hepatology and Endoscopy Practice — journals.lww.com — https://journals.lww.com/ghep/fulltext/2026/01000/assessing_the_relevance_of_baveno_vi_guidelines.1.aspx
11. Medical care setting is associated with survival in acute upper gastro-intestinal bleeding: A cohort study — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S159086582030044X
12. Acute upper gastrointestinal bleeding due to portal hypertension in children: What is the best timing of endoscopy? — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1590865821007799
13. Acute Variceal Hemorrhage — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S105251570700013X
14. Variceal bleeding in cirrhotic patients - Oxford Academic — academic.oup.com — https://academic.oup.com/gastro/article-pdf/5/3/185/19500870/gox024.pdf
15. Timing of endoscopy in patients with acute variceal bleeding in cirrhosis: an updated systematic review and meta-analysis - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12211783
16. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - PubMed — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pubmed/36174643
17. Impact of timing of endoscopy on clinical outcomes in cirrhotic patients with esophageal variceal bleeding: a monocentric retrospective study from Vietnam — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12333083
18. Recent advances in the management of variceal bleeding — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5421505
19. Management Strategies for Refractory Esophageal Varices — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12177223
20. Upper Gastrointestinal Bleeding - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK470300
21. Endoscopic Management of Gastric Varices | AASLD — www.aasld.org — https://www.aasld.org/liver-fellow-network/core-series/clinical-pearls/endoscopic-management-gastric-varices
22. Why is retrograde transvenous obliteration used to treat gastrofundal variceal bleeding? | AASLD — www.aasld.org — https://www.aasld.org/liver-fellow-network/core-series/why-series/why-retrograde-transvenous-obliteration-used-treat
23. [PDF] EASL Clinical Practice Guidelines for the management of patients ... — easl.eu — https://easl.eu/wp-content/uploads/2018/10/decompensated-cirrhosis-English-report.pdf
24. Treatment for bleeding oesophageal varices in people with ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013155.pub2/references

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.